Latest Articles
Chemo-Free Regimen for Endometrial Cancer Produces Durable Responses, Favorable PFS - MedPage Today
Chemo-Free Regimen for Endometrial Cancer Produces Durable Responses, Favorable PFS MedPage Today
Published: April 14, 2026, 2:27 p.m.
King Saud University study identifies proteomic differences in obesity-related endometrial cancer - Gulf Daily News
King Saud University study identifies proteomic differences in obesity-related endometrial cancer Gulf Daily News
Published: April 14, 2026, 1 p.m.
Study finds obesity biomarkers for endometrial cancer - Arab News
Study finds obesity biomarkers for endometrial cancer Arab News
Published: April 14, 2026, 12:54 p.m.
Study finds obesity biomarkers for endometrial cancer - Arab News PK
Study finds obesity biomarkers for endometrial cancer Arab News PK
Published: April 14, 2026, 12:50 p.m.
HER2 ADC Shows Promise in Recurrent Endometrial Cancer - Medscape
HER2 ADC Shows Promise in Recurrent Endometrial Cancer Medscape
Published: April 14, 2026, 11:41 a.m.
Bar Levy: What Can We Do to Promote Early Detection of Endometrial Cancer? - Oncodaily
Bar Levy: What Can We Do to Promote Early Detection of Endometrial Cancer? Oncodaily
Published: April 14, 2026, 10:55 a.m.
King Saud University Study Identifies Proteomic Differences in Obesity-Related Endometrial Cancer - وكالة الأنباء السعودية
King Saud University Study Identifies Proteomic Differences in Obesity-Related Endometrial Cancer وكالة الأنباء السعودية
Published: April 14, 2026, 9:39 a.m.
BioNTech, DualityBio tout 'clinically meaningful' efficacy for ADC in mid-stage endometrial cancer trial - BioSpace
BioNTech, DualityBio tout 'clinically meaningful' efficacy for ADC in mid-stage endometrial cancer trial BioSpace
Published: April 13, 2026, 5:57 p.m.
Near-Perfect Disease Control for Bispecific in Advanced Endometrial Cancer - MedPage Today
Near-Perfect Disease Control for Bispecific in Advanced Endometrial Cancer MedPage Today
Published: April 13, 2026, 3:43 p.m.
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer - TipRanks
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer TipRanks
Published: April 13, 2026, 12:29 p.m.
Link copied to clipboard!